Express Scripts, Medco
More people seem to sign on in opposition to the $29.1 billion Express Scripts Medco merger each month, but Wall Street is betting the companies will get their way.
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login
to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information:
FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch